Matches in Wikidata for { <http://www.wikidata.org/entity/Q71244113> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q71244113 description "article scientifique publié en 1983" @default.
- Q71244113 description "artículu científicu espublizáu en febreru de 1983" @default.
- Q71244113 description "im Februar 1983 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71244113 description "scientific article published on 01 February 1983" @default.
- Q71244113 description "wetenschappelijk artikel" @default.
- Q71244113 description "наукова стаття, опублікована в лютому 1983" @default.
- Q71244113 name "Phase II clinical evaluation of intravenous 4'-" @default.
- Q71244113 name "Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer" @default.
- Q71244113 name "Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer" @default.
- Q71244113 type Item @default.
- Q71244113 label "Phase II clinical evaluation of intravenous 4'-" @default.
- Q71244113 label "Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer" @default.
- Q71244113 label "Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer" @default.
- Q71244113 prefLabel "Phase II clinical evaluation of intravenous 4'-" @default.
- Q71244113 prefLabel "Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer" @default.
- Q71244113 prefLabel "Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer" @default.
- Q71244113 P1433 Q71244113-5A8C5FA6-F64D-4861-9D59-690114C710ED @default.
- Q71244113 P1476 Q71244113-89FB3DEB-5C98-488B-A673-13904025ED9F @default.
- Q71244113 P2093 Q71244113-0B17005D-7547-4168-92C0-ABFA3D7F2552 @default.
- Q71244113 P2093 Q71244113-1E94DEE2-41C1-4ED1-9256-A23E7EBB654E @default.
- Q71244113 P2093 Q71244113-4B74D86F-F225-411B-B0FB-24A13FFBC054 @default.
- Q71244113 P2093 Q71244113-90F767DE-45AE-4D92-A9E8-030AF3370F69 @default.
- Q71244113 P2093 Q71244113-9FD5C6B2-36CF-473B-9A85-F134C62FD1B5 @default.
- Q71244113 P2093 Q71244113-BFE8A3F5-976B-47CB-913F-189685B15AE5 @default.
- Q71244113 P2093 Q71244113-F47D98B2-2A82-4950-BB37-4F70AB09BC52 @default.
- Q71244113 P304 Q71244113-B17224FE-A17D-401D-BBF2-DC7484D50125 @default.
- Q71244113 P31 Q71244113-A77C694D-DD01-46B0-B130-99F6A3AEA08A @default.
- Q71244113 P433 Q71244113-7392C6DA-89F2-4833-8BE7-C2C742DD871A @default.
- Q71244113 P478 Q71244113-EB13C56F-8A4A-45AD-82F8-021E13009369 @default.
- Q71244113 P577 Q71244113-0B66B6D9-E658-4140-8B37-2256F78F5577 @default.
- Q71244113 P698 Q71244113-EE61FBB3-4097-4261-BE4B-5EFC337075A4 @default.
- Q71244113 P921 Q71244113-0E1A7843-4136-4472-A114-35B4E3CA8208 @default.
- Q71244113 P698 6687657 @default.
- Q71244113 P1433 Q2886177 @default.
- Q71244113 P1476 "Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer" @default.
- Q71244113 P2093 "Bedikian AY" @default.
- Q71244113 P2093 "Bennetts RW" @default.
- Q71244113 P2093 "Bodey GP" @default.
- Q71244113 P2093 "Karlin DA" @default.
- Q71244113 P2093 "Legha SS" @default.
- Q71244113 P2093 "Stroehlein JR" @default.
- Q71244113 P2093 "Valdivieso M" @default.
- Q71244113 P304 "39-44" @default.
- Q71244113 P31 Q13442814 @default.
- Q71244113 P433 "1" @default.
- Q71244113 P478 "6" @default.
- Q71244113 P577 "1983-02-01T00:00:00Z" @default.
- Q71244113 P698 "6687657" @default.
- Q71244113 P921 Q188874 @default.